Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

Published:2014-01 Issue:1 Volume:75 Page:43-49
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Sormani Maria Pia¹,Arnold Douglas L.²,De Stefano Nicola³

Affiliation:

1. Biostatistics Unit, Department of Health Sciences; University of Genoa; Genoa Italy

2. McConnell Brain Imaging Centre; Montreal Neurological Institute and Hospital; Montreal Canada

3. Department of Medicine; Surgery, and Neuroscience, University of Siena; Siena Italy

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference28 articles.

1. Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach;Sormani;Ann Neurol,2009

2. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomized trials;Sormani;Lancet Neurol,2013

3. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis;Sormani;Mult Scler,2011

4. MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients;Sormani;Neurology,2002

5. MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b;Sormani;Neurology,2003

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network;Multiple Sclerosis and Related Disorders;2024-11

2. Assessing disease progression and treatment response in progressive multiple sclerosis;Nature Reviews Neurology;2024-09-09

3. The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: a five-year prospective mono-center study;Multiple Sclerosis and Related Disorders;2024-09

4. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis;The Lancet Regional Health - Europe;2024-09

5. Data-driven risk/benefit estimator for multiple sclerosis therapies;2024-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3